News & Articles
Selected Filters:
Biomarker research – Immuno-oncology, COVID-19, proteomics and more
Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development
Agilent announces launch of global biomarker pathologist training program
Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques
Siemens Healthineers is the first leading diagnostics company offering a quantitative COVID-19 test to measure neutralizing antibodies
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
Top new resources to advance your immuno-oncology research
Exclusive interviews, free downloads, the latest methods and much more to help support your immuno-oncology research
Virtual Neuroscience Summit 2020: Full meeting agenda
From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18
Mayo Clinic collaborates with Vocalis Health for clinical development of vocal biomarkers
Research study intends to develop vocal biomarker for pulmonary hypertension
Nominate your favorite new lab product for a Scientists’ Choice Award: Nominations open today
Which new products made the most difference to your lab work this year?
Biomarker discovery for lysosomal storage disorders using a metabolomic approach: Your questions answered
Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
MIS-C detection: Beckman Coulter partners with BARDA in rapid diagnostic for pediatric complication of SARS-CoV-2
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
The value of SARS-CoV-2 serology testing and the role of neutralization
Join us on Monday, October 26, to learn about the role serology plays in the clinician toolbox for managing COVID-19
Collaboration brings clarity: Understanding SARS-CoV-2-host interactions
We speak with Dr. Ed Emmott, founder of The Emmott Lab & COVID-19 Mass Spec Coalition member, about his latest research into the disease
Cobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021
The collaboration will ensure GMP production of material for the Phase 1 clinical trial of Scancell’s DNA vaccine against SARS-CoV-2
Digital chemistry’ breakthrough turns words into molecules
A new system capable of automatically turning words into molecules on demand will open up the digitisation of chemistry, scientists say
Chemical laboratory changes for Covid-19 patients
World-class speaker lineup announced for Virtual Neuroscience Summit 2020
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Abbott's FreeStyle Libre 3 System receives CE Mark
With the smallest and thinnest wearable glucose sensor, FreeStyle Libre 3 users may view their glucose levels discreetly and conveniently, anytime
Coronavirus (COVID-19) update: FDA authorizes first point-of-care antibody test for COVID-19
The Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for emergency use by certain labs in July 2020
Rapid 90-minute COVID-19 test shown to be highly accurate
In the research, the high-speed tests, which do not require a laboratory and can be performed in cartridges smaller than a mobile phone
Raman microscopy: Comprehensive characterization of polymers
Join us on Monday, September 28, for this expert-led webinar on the intricacies of Raman technology
Study finds that high levels of a growth factor increases risk for several cancers
These findings could lead to new preventative strategies, including diet and lifestyle interventions
Thermo Fisher announces collaborations to meet unmet clinical needs in biomarker discovery and characterization
Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
Oxford University researchers target previously unknown ‘genetic vulnerability’ in breast cancer cells
The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors























